CCRC 2021 Pre-Conference Survey
We want to hear from you on how to make this year’s Canadian Cancer Research Conference (CCRC) a meaningful and unique experience!
To ensure the success of our first-ever virtual conference this November, we are asking all those who are interested in attending to take 3-5 minutes to complete a short survey sharing your interests and feedback. The results of this survey will be used to inform the format, delivery, and scientific content of the conference to make the event as valuable, engaging, and accessible to our community as possible.
Please complete the survey by April 19.
We appreciate your time and feedback and look forward to hearing from you. If you have any questions or comments, please contact us at: ccraconference.secretariat@partnershipagainstcancer.ca
CCRA Welcomes New Patient/Family Representatives
Effective January 1st, 2025, the CCRA Advisory Board welcomes two new patient and family representatives, Adrienne Co-Dyre and Chantale Thurston, both well known cancer research advocates. Adrienne has used her accumulated knowledge and experience to inspire ch... Read More »
Effective January 1st, 2025, the CCRA Advisory Board welcomes two new patient and family representatives, Adrienne Co-Dyre and Chantale Thurston, both well known cancer research advocates. Adrienne has used her accumulated knowledge and experience to inspire ch... Read More »
New Member to the CCRA Advisory Board
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a P... Read More »
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a P... Read More »